Investigation of cell death mechanisms in human lymphatic endothelial cells undergoing photodynamic therapy

Photodiagnosis and Photodynamic Therapy

Volumn 14, Issue , 2016, Pages 57-65

  Wachowska, Malgorzata ^a   Osiak, Agata ^a,b   Muchowicz, Angelika ^a   Gabrysiak, Magdalena ^a,e   Domagała, Antoni ^a   Kilarski, Witold W ^c,d   Golab, Jakub ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF CARDIOLOGY   (Poland)

^c EPFL   (Switzerland)

^d UNIVERSITY OF CHICAGO   (United States)

^e THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

Apoptosis; Autophagy; Lymphatic endothelial cells; Photodynamic therapy

Indexed keywords

VERTEPORFIN; PHOTOSENSITIZING AGENT; PORPHYRIN;

ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOSE RESPONSE; ELECTROPHORESIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LYMPHATIC ENDOTHELIAL CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ANIMAL; CYTOLOGY; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; LYMPH; PHOTOCHEMOTHERAPY; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LYMPH; MICE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 84958961320     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2016.02.004     Document Type: Article

References (39)

1. Hogan B.M., Black B.L. Developmental biology: diversity in the lymphatic vasculature. Nature 2015, 522:37-38.
2. Alitalo K. The lymphatic vasculature in disease. Nat. Med. 2011, 17:1371-1380.
3. Maby-El Hajjami H., Petrova T.V. Developmental and pathological lymphangiogenesis: from models to human disease. Histochem. Cell Biol. 2008, 130:1063-1078.
4. Shayan R., Achen M.G., Stacker S.A. Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 2006, 27:1729-1738.
5. Lohela M., Saaristo A., Veikkola T., Alitalo K. Lymphangiogenic growth factors, receptors and therapies. Thromb. Haemost. 2003, 90:167-184.
6. Pytowski B., Goldman J., Persaud K., Wu Y., Witte L., Hicklin D.J., et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J. Natl. Cancer Inst. 2005, 97:14-21.
7. Nakamura Y., Yasuoka H., Tsujimoto M., Imabun S., Nakahara M., Nakao K., et al. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res. Treat. 2005, 91:125-132.
8. Allison R.R. Photodynamic therapy: oncologic horizons. Future Oncol. 2014, 10:123-124.
9. Buytaert E., Dewaele M., Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta 2007, 1776:86-107.
10. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., et al. Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 2011, 61:250-281.
11. Fateye B., Wan A., Yang X., Myers K., Chen B. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor. Photodiagn. Photodyn. Ther. 2015, 12:19-26.
12. Seshadri M., Spernyak J.A., Mazurchuk R., Camacho S.H., Oseroff A.R., Cheney R.T., et al. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clin. Cancer Res. 2005, 11:4241-4250.
13. Calzavara-Pinton P.G., Venturini M., Sala R. Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J. Eur. Acad. Dermatol. Venereol. 2007, 21:293-302.
14. Tammela T., Saaristo A., Holopainen T., Yla-Herttuala S., Andersson L.C., Virolainen S., et al. Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Sci. Transl. Med. 2011, 3:69ra11.
15. Firczuk M., Gabrysiak M., Barankiewicz J., Domagala A., Nowis D., Kujawa M., et al. GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy. Cell Death Dis. 2013, 4:e741.
16. Kilarski W.W., Muchowicz A., Wachowska M., Mezyk-Kopec R., Golab J., Swartz M.A., et al. Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis. Angiogenesis 2014, 17:347-357.
17. Kilarski W.W., Guc E., Teo J.C., Oliver S.R., Lund A.W., Swartz M.A. Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis. PLoS One 2013, 8:e57135.
18. Ly J.D., Grubb D.R., Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 2003, 8:115-128.
19. Collins J.A., Schandi C.A., Young K.K., Vesely J., Willingham M.C. Major DNA fragmentation is a late event in apoptosis. J. Histochem. Cytochem. 1997, 45:923-934.
20. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
21. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther. 2005, 2:1-23.
22. Granville D.J., Shaw J.R., Leong S., Carthy C.M., Margaron P., Hunt D.W., et al. Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis. Am. J. Pathol. 1999, 155:1021-1025.
23. Castano A.P., Mroz P., Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer. 2006, 6:535-545.
24. Chen Z., Woodburn K.W., Shi C., Adelman D.C., Rogers C., Simon D.I. Photodynamic therapy with motexafin lutetium induces redox-sensitive apoptosis of vascular cells. Arterioscler. Thromb. Vasc. Biol. 2001, 21:759-764.
25. Panzarini E., Inguscio V., Dini L. Immunogenic cell death: can it be exploited in photodynamic therapy for cancer?. Biomed. Res. Int. 2013, 2013:482160.
26. Mroz P., Yaroslavsky A., Kharkwal G.B., Hamblin M.R. Cell death pathways in photodynamic therapy of cancer. Cancers (Basel) 2011, 3:2516-2539.
27. Lee S.H., Meng X.W., Flatten K.S., Loegering D.A., Kaufmann S.H. Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm. Cell Death Differ. 2013, 20:64-76.
28. Inoue K., Fukuhara H., Kurabayashi A., Furihata M., Tsuda M., Nagakawa K., et al. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma. Cancer Sci. 2013, 104:765-772.
29. Plaetzer K., Kiesslich T., Oberdanner C.B., Krammer B. Apoptosis following photodynamic tumor therapy: induction, mechanisms and detection. Curr. Pharm. Des. 2005, 11:1151-1165.
30. Chiu S.M., Oleinick N.L. Dissociation of mitochondrial depolarization from cytochrome c release during apoptosis induced by photodynamic therapy. Br. J. Cancer 2001, 84:1099-1106.
31. Chan W.H. Photodynamic treatment induces an apoptotic pathway involving calcium, nitric oxide, p53, p21-activated kinase 2, and c-Jun N-terminal kinase and inactivates survival signal in human umbilical vein endothelial cells. Int. J. Mol. Sci. 2011, 12:1041-1059.
32. Chen N., Debnath J. Autophagy and tumorigenesis. FEBS Lett. 2010, 584:1427-1435.
33. Kessel D. Promotion of PDT efficacy by a Bcl-2 antagonist. Photochem. Photobiol. 2008, 84:809-814.
34. Kessel D., Vicente M.G., Reiners J.J. Initiation of apoptosis and autophagy by photodynamic therapy. Autophagy 2006, 2:289-290.
35. Fateye B., Li W., Wang C., Chen B. Combination of phosphatidylinositol 3-kinases pathway inhibitor and photodynamic therapy in endothelial and tumor cells. Photochem. Photobiol. 2012, 88:1265-1272.
36. Kessel D., Reiners J.J. Apoptosis and autophagy after mitochondrial or endoplasmic reticulum photodamage. Photochem. Photobiol. 2007, 83:1024-1028.
37. Garg A.D., Krysko D.V., Verfaillie T., Kaczmarek A., Ferreira G.B., Marysael T., et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 2012, 31:1062-1079.
38. Garg A.D., Nowis D., Golab J., Vandenabeele P., Krysko D.V., Agostinis P. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim. Biophys. Acta 2010, 1805:53-71.
39. Jalili A., Makowski M., Switaj T., Nowis D., Wilczynski G.M., Wilczek E., et al. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin. Cancer Res. 2004, 10:4498-4508.